Ad
Tuesday, 8 October 2019
GSK recalls popular heartburn drug Zantac globally after cancer scare
GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a "precaution", days after the U.S. Food and Drug Administration found "unacceptable" levels of probable cancer-causing impurity in the drug.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment